Genomic Testing and Current Trends in the Treatment of Non-Small Cell Lung Cancer

Listen Now

Topics Covered

• Overview of Non-Small Cell Lung Cancer, in the Context of COVID-19
• Definition of Genomics & Genomic Testing
• The Difference between Genomics & Genetics
• The Role of Genomic Testing in the Treatment of Non-Small Cell Lung Cancer
• Specific Examples of How Genomic Testing May Inform Treatment Decisions
• Precision Medicine
• Current Research in Genomics
• Liquid Biopsies
• The Role of the Pathologist
• Reviewing Your Pathology Report with Your Pathologist & Health Care Team
• Key Questions to Ask Your Health Care Team about Genomic Testing & Its Benefits for Your Treatment
• Follow-Up Care
• Guidelines to Prepare for Telehealth/Telemedicine Appointments, including Technology, Prepared List of Questions
• Questions for Our Panel of Experts

Our Panel of Experts

Joshua K. Sabari, MD

Attending Physician, Thoracic Medical Oncology, Assistant Professor of Medicine, NYU Langone Health, Perlmutter Cancer Center

Jia Luo, MD

Physician, Attending, Thoracic Oncology Service, Dana-Farber Cancer Institute, Instructor in Medicine, Harvard Medical School

Nikki Martin, MA

Senior Director of Precision Medicine Initiatives, LUNGevity Foundation

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Senior Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on June 21, 2022.